Medical research: Ebola therapy protects severely ill monkeys
- PMID: 25171470
- PMCID: PMC4469351
- DOI: 10.1038/nature13746
Medical research: Ebola therapy protects severely ill monkeys
Abstract
A blend of three monoclonal antibodies has completely protected monkeys against a lethal dose of Ebola virus. Unlike other post-infection therapies, the treatment works even at advanced stages of the disease.
Comment on
-
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.Nature. 2014 Oct 2;514(7520):47-53. doi: 10.1038/nature13777. Epub 2014 Aug 29. Nature. 2014. PMID: 25171469 Free PMC article.
References
-
- Feldmann H, Sanchez A, Geisbert TW. In: Fields Virology. 6. Knipe DM, Howley PM, editors. Lippincott Williams & Wilkins; 2013. pp. 923–956.
-
- Baize S, et al. N Engl J Med. 2014 http://dx.doi.org/10.1056/NEJMoa1404505. - DOI - PubMed
-
- Geisbert TW, et al. Lancet. 2003;362:1953–1958. - PubMed
-
- Hensley LE, et al. J Infect Dis. 2007;196(Suppl 2):S390–S399. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical